These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium. Bogaerts P, Berhin C, Nizet H, Glupczynski Y. Helicobacter; 2006 Oct; 11(5):441-5. PubMed ID: 16961806 [Abstract] [Full Text] [Related]
29. Synthesis and in vitro selective anti-Helicobacter pylori activity of pyrazoline derivatives. Chimenti F, Bizzarri B, Manna F, Bolasco A, Secci D, Chimenti P, Granese A, Rivanera D, Lilli D, Scaltrito MM, Brenciaglia MI. Bioorg Med Chem Lett; 2005 Feb 01; 15(3):603-7. PubMed ID: 15664821 [Abstract] [Full Text] [Related]
30. Synthesis and in vitro antibacterial activity of fluoroquinolone derivatives containing 3-(N'-alkoxycarbamimidoyl)-4-(alkoxyimino) pyrrolidines. Guo Q, Feng LS, Liu ML, Zhang YB, Chai Y, Lv K, Guo HY, Han LY. Eur J Med Chem; 2010 Nov 01; 45(11):5498-506. PubMed ID: 20833454 [Abstract] [Full Text] [Related]
31. Preparation, characterization, and anti-Helicobacter pylori activity of Bi3+-Hericium erinaceus polysaccharide complex. Zhu Y, Chen Y, Li Q, Zhao T, Zhang M, Feng W, Takase M, Wu X, Zhou Z, Yang L, Wu X. Carbohydr Polym; 2014 Sep 22; 110():231-7. PubMed ID: 24906751 [Abstract] [Full Text] [Related]
33. A novel compound from celery seed with a bactericidal effect against Helicobacter pylori. Zhou Y, Taylor B, Smith TJ, Liu ZP, Clench M, Davies NW, Rainsford KD. J Pharm Pharmacol; 2009 Aug 22; 61(8):1067-77. PubMed ID: 19703351 [Abstract] [Full Text] [Related]
37. Metronidazole-flavonoid derivatives as anti-Helicobacter pylori agents with potent inhibitory activity against HPE-induced interleukin-8 production by AGS cells. Li HQ, Xu C, Li HS, Xiao ZP, Shi L, Zhu HL. ChemMedChem; 2007 Sep 22; 2(9):1361-9. PubMed ID: 17628869 [Abstract] [Full Text] [Related]
38. Metal complexes with the quinolone antibacterial agent N-propyl-norfloxacin: synthesis, structure and bioactivity. Efthimiadou EK, Psomas G, Sanakis Y, Katsaros N, Karaliota A. J Inorg Biochem; 2007 Mar 22; 101(3):525-35. PubMed ID: 17239442 [Abstract] [Full Text] [Related]
40. Structure-activity relationship study of a series of N-substituted piperazinyl-fluoroquinolones as anti-Helicobacter pylori agents. Foroumadi A, Safavi M, Emami S, Siavoshi F, Najjari S, Safari F, Shafiee A. Med Chem; 2008 Sep 22; 4(5):498-502. PubMed ID: 18782047 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]